Skip to main content

DiaMedica Therapeutics Inc.

DMAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401040

No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in DiaMedica Therapeutics Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
40
+9 vs. Q2 2024
Shares held
5.58M
+622.6K (+12.6%) vs. Q2 2024
Total value
$23.3M
+$8.70M (+59.5%) vs. Q2 2024
New holders
13
9 more added
Sold out
4
6 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DMAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 40 institutions
Q1 2021: 41 institutionsQ2 2021: 43 institutionsQ3 2021: 34 institutionsQ4 2021: 39 institutionsQ1 2022: 34 institutionsQ2 2022: 28 institutionsQ3 2022: 26 institutionsQ4 2022: 28 institutionsQ1 2023: 25 institutionsQ2 2023: 32 institutionsQ3 2023: 36 institutionsQ4 2023: 38 institutionsQ1 2024: 32 institutionsQ2 2024: 32 institutionsQ3 2024: 40 institutionsQ4 2024: 45 institutionsQ1 2025: 57 institutionsQ2 2025: 58 institutionsQ3 2025: 78 institutionsQ4 2025: 92 institutionsQ1 2026: 99 institutionsQ2 2026: 88 institutions
Value heldQ3 2024: $23.3M
Q1 2021: $52.1MQ2 2021: $16.9MQ3 2021: $11.2MQ4 2021: $15.0MQ1 2022: $10.0MQ2 2022: $7.42MQ3 2022: $3.14MQ4 2022: $3.99MQ1 2023: $3.93MQ2 2023: $15.1MQ3 2023: $11.0MQ4 2023: $11.3MQ1 2024: $13.2MQ2 2024: $14.9MQ3 2024: $23.3MQ4 2024: $36.6MQ1 2025: $28.5MQ2 2025: $34.5MQ3 2025: $82.9MQ4 2025: $96.0MQ1 2026: $79.6MQ2 2026: $87.8M
Institutions holding DMAC and their total value by quarter
QuarterHoldersValue
Q2 202688$87.8M
Q1 202699$79.6M
Q4 202592$96.0M
Q3 202578$82.9M
Q2 202558$34.5M
Q1 202557$28.5M
Q4 202445$36.6M
Q3 202440$23.3M
Q2 202432$14.9M
Q1 202432$13.2M
Q4 202338$11.3M
Q3 202336$11.0M
Q2 202332$15.1M
Q1 202325$3.93M
Q4 202228$3.99M
Q3 202226$3.14M
Q2 202228$7.42M
Q1 202234$10.0M
Q4 202139$15.0M
Q3 202134$11.2M
Q2 202143$16.9M
Q1 202141$52.1M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding DiaMedica Therapeutics Inc.; share changes are against Q2 2024.

Institutions holding DMAC in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Cooperman Leon G1,511,739$6.33M0.27%+111,739+8.0%Added
Vanguard Group Inc1,049,029$4.40M0.00%+31,627+3.1%Added
First Manhattan Co839,081$3.52M0.01%00.0%Unchanged
Paragon Associates & Paragon Associates II Joint Venture482,614$2.02M3.63%00.0%Unchanged
Bleichroeder LP382,317$1.60M0.43%00.0%Unchanged
Geode Capital Management, LLC306,958$1.29M0.00%+70,070+29.6%Added
LPL Financial LLC140,500$588.7K0.00%+123,000+702.9%Added
Northern Trust Corp120,290$504.0K0.00%−99−0.1%Reduced
Morgan Stanley110,016$461.0K0.00%+23,816+27.6%Added
BlackRock, Inc.107,790$451.6K0.00%+107,790New
Susquehanna International Group, LLP101,450$425.1K0.00%+58,077+133.9%Added
State Street Corp68,729$288.0K0.00%00.0%Unchanged
Qube Research & Technologies Ltd52,089$218.3K0.00%+52,089New
Catalyst Financial Partners LLC38,457$161.1K0.03%00.0%Unchanged
Millennium Management LLC33,690$141.2K0.00%+33,690New
Ronald Blue Trust, Inc.44,247$130.5K0.00%+44,247New
Jefferies Financial Group Inc.26,000$108.9K0.00%+26,000New
Citigroup Inc22,097$92.6K0.00%+22,097New
Stonebridge Capital Advisors LLC17,500$73.3K0.01%−2,500−12.5%Reduced
Dimensional Fund Advisors LP16,959$71.1K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA16,500$69.1K0.00%+1,300+8.6%Added
Charles Schwab Investment Management Inc13,251$55.5K0.00%00.0%Unchanged
UBS Group AG12,739$53.4K0.00%+12,739New
Citadel Advisors LLC11,831$49.6K0.00%+3,418+40.6%Added
Raymond James Financial Services Advisors, Inc.11,520$48.3K0.00%+11,520New
Magnolia Capital Advisors LLC10,000$41.9K0.02%00.0%Unchanged
Point72 Asia (Singapore) Pte. Ltd.9,498$39.8K0.01%+9,498New
Massmutual Trust Co FSB4,824$20.2K0.00%00.0%Unchanged
US Bancorp4,335$18.2K0.00%00.0%Unchanged
Simplex Trading, LLC3,662$15.0K0.00%+3,662New
Cubist Systematic Strategies, LLC3,263$13.7K0.00%+3,263New
Naples Money Management LLC2,068$8.66K0.01%−910−30.6%Reduced
Tower Research Capital LLC (TRC)1,118$4.68K0.00%−770−40.8%Reduced
TD Waterhouse Canada Inc.1,070$4.45K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,055$4.42K0.00%−1,000−48.7%Reduced
Legend Financial Advisors, Inc.1,000$4.19K0.00%00.0%Unchanged
Royal Bank of Canada805$3.00K0.00%−251−23.8%Reduced
Bank of America Corp213$8920.00%+30+16.4%Added
Cornerstone Planning Group LLC80$3460.00%+80New
JPMorgan Chase & Co27$1130.00%+27New
Aristides Capital LLC0$00.00%−106,333−100.0%Sold out
Jane Street Group, LLC0$00.00%−15,091−100.0%Sold out
Federation des caisses Desjardins du Quebec0$00.00%−230−100.0%Sold out
Toronto Dominion Bank0$00.00%−24−100.0%Sold out
BlackRock Inc.––––Not filed